Linda Malek
Overview
Linda Malek is a partner in Crowell’s Health Care and Privacy & Cybersecurity Groups, where she advises a broad array of health care and life sciences clients on compliance with federal, state, and international law governing clinical research, data privacy, cybersecurity, and fraud and abuse. Her clients include national hospitals systems and academic medical centers, genetic and biotechnology companies, pharmaceutical companies, medical device companies, financial institutions involved in healthcare services, research foundations and international scientific organizations.
Career & Education
- New York
Office of the Corporation Counsel, Division of Legal Counsel
- New York
- Walla Walla University, B.A., cum laude
- University of Virginia School of Law, J.D.,
Editorial Board Member, Journal of Law and Politics
Recipient, Mary Claiborne and Roy H. Ritter Award, The University of Virginia School of Law
- New York
- Board Member, NYBIO
- Trustee, Lucy B. Moses Foundation
- Former member of Educational Advisory Board, International Association of Privacy Professionals
- Founding Board, National Board of Health Lawyers, a division of NBTA (National Board of Trial Advocacy)
- American Bar Association, Health Reform Task Force
- American Health Lawyers Association
- French
Linda's Insights
Client Alert | 2 min read | 04.24.24
FTC Continues Focus on Tracking Technologies and Personal Health Data
The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”
Press Coverage | 03.22.24
Speaking Engagement | 03.13.24
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
Event | 03.13.24 - 03.14.24
Recognition
- Best Lawyers in America: 2022 - 2024
- Super Lawyers: 2013 - 2024
Linda's Insights
Client Alert | 2 min read | 04.24.24
FTC Continues Focus on Tracking Technologies and Personal Health Data
The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”
Press Coverage | 03.22.24
Speaking Engagement | 03.13.24
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
Event | 03.13.24 - 03.14.24
Insights
Speaking Engagement | 03.13.24
Linda's Insights
Client Alert | 2 min read | 04.24.24
FTC Continues Focus on Tracking Technologies and Personal Health Data
The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”
Press Coverage | 03.22.24
Speaking Engagement | 03.13.24
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
Event | 03.13.24 - 03.14.24
